Methylenedioxybenzylamphetamine

Methylenedioxybenzylamphetamine (MDBA) is a psychoactive drug and a member of the phenethylamine and amphetamine chemical classes. It is known for its entactogenic effects.

Chemistry

Methylenedioxybenzylamphetamine is a chemical compound with the molecular formula C11H15NO2. It belongs to the class of organic compounds known as benzodioxoles. These are organic compounds containing a benzene ring fused to either isomers of dioxole. Dioxole is a five-membered unsaturated ring of two oxygen atoms and three carbon atoms.

Pharmacology

The pharmacological action of MDBA is similar to that of other psychoactive drugs. It acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). This means it increases the levels of these neurotransmitters in the brain by inhibiting their reuptake into the presynaptic neuron, leading to an increase in the extracellular concentrations of these neurotransmitters and therefore an increase in neurotransmission.

Effects

The effects of MDBA can vary greatly depending on the dose, the user's individual physiology, and the environment in which it's used. Common effects include feelings of openness, euphoria, empathy, love, and increased self-awareness. These effects can be accompanied by side effects such as jaw clenching, lack of appetite, and insomnia.

Risks

Like other psychoactive substances, MDBA carries risks. These can include dehydration, hyperthermia, bruxism, insomnia, and in rare cases, serotonin syndrome. Long-term use can lead to drug dependence and severe withdrawal symptoms.

Legal Status

The legal status of MDBA varies by country. In many countries, it is classified as a controlled substance, making its manufacture, distribution, or use without a license illegal.

See Also

• MDMA
• Amphetamine
• Psychoactive drug
• Serotonin syndrome